Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

32.8K
Overview
32.8K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Affinity and Avidity01:41

Affinity and Avidity

38.4K
Overview
38.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severity of SARS-CoV-2 infection increases the risk of generalized anxiety disorder, major depressive disorder, and post-traumatic stress disorder in COVID-19 survivors: a prospective longitudinal cohort study.

Brain, behavior, & immunity - health·2026
Same author

Immunosenescence and human healthspan. Lessons from centenarians.

Current opinion in immunology·2026
Same author

Mpox virus immunology: exploring links to autoimmune diseases.

Current opinion in immunology·2026
Same author

Health status characteristics and aging determinants of centenarians in Colombia: a real-life expanded cohort profile description.

BMC geriatrics·2026
Same author

Biological age and immunosenescence in Colombian centenarians.

npj aging·2026
Same author

NET Biomarkers in COVID-19 and Post-COVID Syndrome: a Comprehensive Analysis.

Journal of clinical immunology·2026

Related Experiment Video

Updated: Jan 13, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K

Autoimmunity, epitope analysis, and molecular mimicry.

Manuel Rojas1, Yeny Acosta-Ampudia2, Diana M Monsalve2

  • 1Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, CA 95616, USA; Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.

Current Opinion in Immunology
|October 28, 2025
PubMed
Summary

Infections can trigger autoimmune diseases (ADs) through molecular mimicry and other mechanisms. Advanced computational methods help study these triggers for better vaccine development and understanding environmental factors in ADs.

More Related Videos

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

13.2K
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

7.3K

Related Experiment Videos

Last Updated: Jan 13, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

13.2K
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

7.3K

Area of Science:

  • Immunology
  • Computational Biology
  • Pathogenesis of Autoimmune Diseases

Background:

  • Infectious agents are implicated as triggers for autoimmune diseases (ADs) in susceptible individuals.
  • Molecular mimicry is a proposed mechanism where infections initiate autoimmunity by breaking peripheral tolerance.
  • Other factors like central tolerance deficiencies, bystander activation, epitope spreading, and sustained antigenic stimulation also contribute to AD etiology.

Purpose of the Study:

  • To explore the role of molecular mimicry and other mechanisms in the initiation of autoimmune diseases.
  • To highlight the importance of advanced computational methods in studying molecular mimicry in AD pathogenesis.
  • To emphasize the need for further research in peptide conformational analysis for vaccine design and understanding environmental influences.

Main Methods:

  • Utilizing epidemiological and experimental evidence.
  • Employing advanced computational techniques such as molecular docking simulations.
  • Performing affinity estimation for human leukocyte antigens (HLAs).
  • Conducting three-dimensional structural analysis of peptides.

Main Results:

  • Molecular mimicry is a significant, but not the only, mechanism linking infections to ADs.
  • Advanced computational and structural analyses are crucial for elucidating molecular mimicry's role.
  • Peptide conformational analysis is vital for future research directions.

Conclusions:

  • Infections can initiate autoimmunity through multiple pathways beyond molecular mimicry.
  • Computational and structural biology approaches are essential tools for investigating autoimmune disease pathogenesis.
  • Further investigation into peptide structure and interactions is key for developing targeted therapies and vaccines for ADs.